Asan Medical Center: clinical-trial pipeline
Asan Medical Center is the sponsor of 577 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 77 are not yet finished and 2 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 288 |
| Phase 2 | 124 |
| Phase 4 | 70 |
| Phase 3 | 45 |
| Phase 1 | 25 |
| Phase 1/2 | 18 |
| Phase 2/3 | 6 |
| Early phase 1 | 1 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 307 |
| Unknown | 156 |
| Recruiting | 50 |
| Terminated | 26 |
| Active, not recruiting | 15 |
| Not yet recruiting | 12 |
| Withdrawn or not authorised | 10 |
| Suspended or halted | 1 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 268 |
| Gastroenterology and liver | 105 |
| Cardiovascular | 66 |
| Nephrology and urology | 53 |
| Infectious disease and vaccines | 42 |
| Immunology and rheumatology | 40 |
| Neurology | 28 |
| Women's health and obstetrics | 26 |
| Respiratory | 25 |
| Rare and genetic diseases | 20 |
| Metabolic and endocrine (diabetes, obesity) | 17 |
| Haematology | 13 |
Countries
| Country | Trials |
|---|---|
| South Korea | 535 |
| Philippines | 2 |
| Canada | 1 |
| China | 1 |
| United Kingdom | 1 |
| Hong Kong SAR China | 1 |
| Japan | 1 |
| Thailand | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-09 | New trial posted | Predicting Endocrine Resistance Using Molecular Imaging and Liquid Biopsy in Metastatic B… |
| 2026-09-16 | New trial posted | Robotic vs Laparoscopic and Open Surgery for Abdominopelvic Cancers |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT05801432 | A Study to Evaluate Coronary Atherosclerosis in Patients With Diabetes Mellitus | Not applicable | Recruiting | South Korea |
| NCT07730840 | Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke | Phase 3 | Not yet recruiting | South Korea |
| NCT06648915 | Lipoprotein(a) and Progression of Aortic Stenosis | Not applicable | Active, not recruiting | South Korea |
| NCT06405958 | Gut Microbiome Analysis in Organ Transplant Recipient | Not applicable | Not yet recruiting | |
| NCT07489092 | Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge | Not applicable | Recruiting | South Korea |
| NCT01935778 | Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advance… | Phase 3 | Recruiting | South Korea |
| NCT06022653 | Asan Aorta and Peripheral Registry | Not applicable | Recruiting | South Korea |
| NCT06855485 | Efficacy and Safety of HANAROSTEN® HOT Plumber™ With Z-EUSIT™ for Pancreatic Pseudocyst Drainage | Not applicable | Recruiting | South Korea |
| NCT07096609 | Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients | Phase 1/2 | Recruiting | South Korea |
| NCT05381194 | BPaL(M) Regimen for the Treatment of MDR/RR-TB | Phase 4 | Recruiting | South Korea |
| NCT06098326 | CyFluATG in Lower Risk MDS | Phase 2 | Active, not recruiting | South Korea |
| NCT07149090 | Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Maligna… | Phase 1/2 | Recruiting | South Korea |
| NCT07175532 | Prospective Multicenter Registry of Patients With Mitral Stenosis Undergoing Percutaneous Mitral Balloon Comm… | Not applicable | Recruiting | South Korea |
| NCT04845828 | Randomized Comparison Between Sentinel Lymph Node Biopsy and Lymph Node Dissection in Early Stage Endometrial… | Not applicable | Recruiting | South Korea |
| NCT01406353 | Early Percutaneous Mitral Intervention in Asymptomatic Moderate Mitral Stenosis | Not applicable | Active, not recruiting | South Korea |
| NCT06098313 | HCT With PTCy in Higher-risk MDS | Phase 2 | Active, not recruiting | South Korea |
| NCT07314073 | [18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer | Phase 2 | Recruiting | South Korea |
| NCT06732856 | A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients… | Phase 1/2 | Recruiting | South Korea |
| NCT07382505 | Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometri… | Not applicable | Not yet recruiting | South Korea |
| NCT04308174 | Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer | Phase 2 | Active, not recruiting | South Korea |
| NCT05661643 | The Efficacy and Safety of Temozolomide in SDH-deficient GIST | Phase 2 | Recruiting | South Korea |
| NCT06421285 | Effect of Preoperative Exercise on the Prevention of Secondary Lymphedema in Breast Cancer Patients | Not applicable | Recruiting | South Korea |
| NCT04010955 | Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-O… | Not applicable | Active, not recruiting | South Korea |
| NCT07530393 | Blood Viscosity and Outcomes After Elective Craniotomy | Not applicable | Recruiting | South Korea |
| NCT05807841 | Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI) | Not applicable | Recruiting | South Korea |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Asan Medical Center clinical trials: 77 open, 51 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/asan-medical-center/, data as of 2026-10-25.